$NXRT

NexPoint Residential Trust, Inc. (NXRT): Results of Operations and Financial Condition

NexPoint Residential Trust, Inc. (NXRT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 nxrt-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 4 August 2026 | NYSE: NXRT EARNINGS SUPPLEMENT: SECOND QUARTER 2026 NEXPOINT RESIDENTIAL TRUST, INC. 300 CRESCENT COURT, SUITE 700 DALLAS, TX 75201 INVESTOR RELATIONS: KRISTEN GRIFFITH NXRT.NEXPOINT.COM NEXPOINT RESIDENTIAL T

Original reporting
Published Aug 4, 2026, 12:23 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 12:33 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$NXRT
Neutral
medium confidence
Mentioned
$NXRT
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$NXRTNeutralMed
01

Why it matters

Traders can use the disclosed FFO/Core FFO/AFFO, same-store occupancy/revenue/NOI changes, and the $22.1M Waterford Loan economics to update near-term earnings expectations and assess whether the company’s upgrade and leasing strategy is offsetting macro rent pressure.

02

Market read

Company-specific earnings and financing disclosures with multiple quantified datapoints, likely to drive REIT earnings-model updates and short-term positioning.

03

What to watch

The excerpt notes the Waterford Loan rate (10.00%) and funding source (revolving credit facility) but does not show the company’s cost of borrowings trend or full debt maturity/refinancing risk, which could dominate valuation sensitivity.

Relevance 7/10Novelty 7/10Timing: filed pre-market today (Aug 4, 2026) with Q2 2026 results

Background

This is NexPoint Residential Trust’s SEC Form 8-K (Item 2.02) with an earnings supplement for the quarter ended June 30, 2026, including operating metrics, dividend, and a newly deployed fixed-rate term loan under its DST bridge-lending program.

Company-level read

Ticker impact

$NXRTNeutralMedium confidence
Context

NXRT reported Q2 2026 results and disclosed a $22.1M 10.00% fixed-rate Waterford Loan under its DST bridge-lending program.

Expected impact

Moderate near-term volatility possible as traders reprice FFO/AFFO trajectory and the economics of the new 10.00% fixed-rate loan versus borrowing costs.

Evidence & confidence

This is a primary 8-K earnings supplement with multiple quantified datapoints (FFO/Core FFO/AFFO, same-store revenue/NOI, dividend, and a newly deployed loan with stated rate and size). However, the excerpt does not include full balance-sheet leverage, guidance detail, or management commentary beyond the highlights, limiting precision on magnitude.

Market effects

Adds datapoints on multifamily REIT operating trends (occupancy up modestly, effective rent and NOI down) and on how DST bridge-lending is being funded and priced.

Highlights a Greensboro-High Point, North Carolina acquisition financed via the DST bridge-lending initiative, which may be relevant for regional multifamily sentiment.

Limited; primarily company-specific REIT earnings and financing activity.

Counterpoint

Despite AFFO growth, same-store NOI and effective rent declined year over year, suggesting the improvement may be driven by non-same-store activity or capital expenditures rather than broad demand strength.

Key entities

  • NexPoint Residential Trust, Inc.

    Reports Q2 2026 results, same-store operating metrics, dividend, and a new $22.1M fixed-rate term loan deployment.

  • Waterford Loan (DST bridge-lending initiative)

    $22.1M fixed-rate term loan bearing 10.00% interest, used to finance a 240-unit stabilized multifamily acquisition in Greensboro-High Point, NC.

Related articles

$NXRTMed

NexPoint Residential Trust, Inc. Q2 2026 Earnings Call Summary

NexPoint Residential Trust, Inc. reported Q2 2026 earnings call updates. Management lowered full-year core FFO guidance, citing a higher forward SOFR curve that reduced projected swap inflows by about $14.6M. Same-store NOI decline was concentrated in Nashville (~85%). Leasing trade-outs turned positive in July. Guidance assumes a late-2026/2027 “clean inflection” with swap protection roll-off of ~$717.5M.

$NXRTMed

NEXPOINT RESIDENTIAL TRUST, INC. REPORTS SECOND QUARTER 2026 RESULTS

NexPoint Residential Trust (NYSE:NXRT) reported Q2 2026 results for the quarter ended June 30. Net loss attributable to common stockholders was $8.6M, with FFO $15.2M and AFFO $19.7M. Revenue rose to $64.6M. Occupancy was 93.5% and same-store revenue and NOI fell. The company deployed a $22.1M 10% fixed-rate DST bridge loan and paid a $0.53 dividend.

$JANMedAI 8/10

JAN Q2 Earnings Call Highlights

Janus Living (NYSE:JAN) reported sequential same-store NOI margin down 40 bps, citing seasonality. Occupancy rose for independent living but fell for skilled nursing. The company acquired two communities for $105M, sold one for $23M, and completed $1B more acquisitions post-quarter. It raised 2026 FFO guidance to $0.95-$0.98 and same-store adjusted NOI growth to 13%-17%.

$JOBYMedAI 8/10

Joby Aviation Q2 Earnings Call Highlights

Joby Aviation (NYSE:JOBY) raised full-year revenue guidance to $115 million to $125 million from $105 million to $115 million. Q2 cash use was about $202 million and GAAP net loss was $245 million, including a $108 million non-cash warrant and earn-out fair value change. For 2H 2026, it expects $385 million to $415 million cash use. The company said aircraft availability is a key constraint on Blade routes and outlined manufacturing, infrastructure, and JV plans with Toyota.

$JHXMedAI 8/10

James Hardie Industries Q1 Earnings Call Highlights

James Hardie (NYSE:JHX) said about one-third of fiber-cement growth came from strategic initiatives, one-third from prior-year destocking comparisons, and the rest from price and mix. June sell-through rose 19%. Deck, Rail & Accessories sales fell 5% to $305.1M with 27.1% Adjusted EBITDA margin. Q2 net sales forecast $1.485B-$1.575B and FY2027 outlook raised; FCF Q1 was $254M and it redeemed $400M notes.

$IXMed

Orix Corp Ads Q1 Earnings Call Highlights

ORIX (NYSE: IX) discussed Q1 results and outlook on an earnings call, including potential Q3 Kioxia sale and valuation losses tied to Kioxia’s end-September share price. ORIX shifted its dividend basis to adjusted profits, targeting an interim dividend of JPY 107.27 per share and full-year JPY 187.36. It reported JPY 115.7B capital gains and about JPY 300B capital-recycling inflows, and continued a JPY 250B buyback.